John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,522 shares at $117.26 ($296K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Seasonal sale ($296k) by EVP & General Counsel — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.26 | 1,261 | $148K | 50.0% |
| 2 | $117.26 | 1,261 | $148K | 50.0% |
| Total | $117.26 avg | 2,522 | $296K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |
| ALXN | SELL | 2017-02-10 | $21K | — | Filing → |